Aurinia Pharmaceuticals, Inc. (AUPH)
15.53
+0.34
(+2.24%)
USD |
NASDAQ |
May 27, 11:44
Aurinia Pharmaceuticals Total Assets (Quarterly) : 724.00M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 1.387B |
| Edesa Biotech, Inc. | 12.38M |
| ProMIS Neurosciences, Inc. | 67.41M |
| Medicus Pharma Ltd. | 5.322M |
| Kiniksa Pharmaceuticals International Plc | 825.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 156.37M |
| Shareholders Equity (Quarterly) | 567.63M |
| Debt to Equity Ratio | 0.1209 |
| Current Ratio | 5.548 |
| Net Debt Paydown Yield | 0.11% |